{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:44:34Z","timestamp":1787805874226,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11912-024-01530-9","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T03:01:51Z","timestamp":1713495711000},"page":"583-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-5823","authenticated-orcid":false,"given":"Mary Kathryn","family":"Abel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ange","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Letourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Melisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle I.","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"1530_CR1","unstructured":"American Cancer Society. American Cancer Society. Cancer facts & figures 2022. Atlanta: American Cancer Society; 2022."},{"issue":"12","key":"1530_CR2","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1200\/JCO.1990.8.12.2062","volume":"8","author":"RJ Epstein","year":"1990","unstructured":"Epstein RJ. Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol. 1990;8(12):2062\u201384. https:\/\/doi.org\/10.1200\/JCO.1990.8.12.2062.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1530_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/GRF.0B013E3181F96B54","volume":"53","author":"D Meirow","year":"2010","unstructured":"Meirow D, Biederman H, Anderson RA, Wallace WHB. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53(4):727\u201339. https:\/\/doi.org\/10.1097\/GRF.0B013E3181F96B54.","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"1530_CR4","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/HUMREP\/DEM027","volume":"22","author":"D Meirow","year":"2007","unstructured":"Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22(6):1626\u201333. https:\/\/doi.org\/10.1093\/HUMREP\/DEM027.","journal-title":"Hum Reprod."},{"issue":"6","key":"1530_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1470-2045(15)70140-3","volume":"16","author":"JH Br\u00e4mswig","year":"2015","unstructured":"Br\u00e4mswig JH, Riepenhausen M, Schellong G. Parenthood in adult female survivors treated for Hodgkin\u2019s lymphoma during childhood and adolescence: a prospective, longitudinal study. Lancet Oncol. 2015;16(6):667\u201375. https:\/\/doi.org\/10.1016\/S1470-2045(15)70140-3.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1530_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737140.2018.1404453","volume":"18","author":"RA Anderson","year":"2018","unstructured":"Anderson RA, Wallace WHB. Pregnancy and live birth after successful cancer treatment in young women: the need to improve fertility preservation and advice for female cancer patients. Expert Rev Anticancer Ther. 2018;18(1):1\u20132. https:\/\/doi.org\/10.1080\/14737140.2018.1404453.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"1530_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/NRCLINONC.2010.133","volume":"8","author":"JM Letourneau","year":"2011","unstructured":"Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8(1):56\u201360. https:\/\/doi.org\/10.1038\/NRCLINONC.2010.133.","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"1530_CR8","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994\u20132001. https:\/\/doi.org\/10.1200\/JCO.2018.78.1914.","journal-title":"J Clin Oncol"},{"key":"1530_CR9","doi-asserted-by":"publisher","unstructured":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022\u20131033. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2019.09.013","DOI":"10.1016\/J.FERTNSTERT.2019.09.013"},{"issue":"11","key":"1530_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/JAMAONCOL.2019.2588","volume":"5","author":"C Catania","year":"2019","unstructured":"Catania C, del Signore E, Spitaleri G. The desire for life and motherhood despite metastatic lung cancer. JAMA Oncol. 2019;5(11):1537\u20138. https:\/\/doi.org\/10.1001\/JAMAONCOL.2019.2588.","journal-title":"JAMA Oncol"},{"issue":"35","key":"1530_CR11","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1200\/JCO.2009.23.0250","volume":"27","author":"GP Quinn","year":"2009","unstructured":"Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27(35):5952\u20137. https:\/\/doi.org\/10.1200\/JCO.2009.23.0250.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1530_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/HUMUPD\/DMP015","volume":"15","author":"S Tschudin","year":"2009","unstructured":"Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update. 2009;15(5):587\u201397. https:\/\/doi.org\/10.1093\/HUMUPD\/DMP015.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1530_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/JHRS.JHRS_39_17","volume":"10","author":"M Awtani","year":"2017","unstructured":"Awtani M, Mathur K, Shah S, Banker M. Infertility stress in couples undergoing intrauterine insemination and in vitro fertilization treatments. J Hum Reprod Sci. 2017;10(3):221\u20135. https:\/\/doi.org\/10.4103\/JHRS.JHRS_39_17.","journal-title":"J Hum Reprod Sci"},{"issue":"13","key":"1530_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/JAMA.2022.15441","volume":"328","author":"A Slomski","year":"2022","unstructured":"Slomski A. Fertility preservation after breast cancer diagnosis. JAMA. 2022;328(13):1289. https:\/\/doi.org\/10.1001\/JAMA.2022.15441.","journal-title":"JAMA"},{"issue":"3","key":"1530_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/J.FERTNSTERT.2008.10.007","volume":"93","author":"RB Quintero","year":"2010","unstructured":"Quintero RB, Helmer A, Huang JQ, Westphal LM. Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril. 2010;93(3):865\u20138. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2008.10.007.","journal-title":"Fertil Steril"},{"issue":"6","key":"1530_CR16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/J.FERTNSTERT.2013.03.029","volume":"99","author":"H Cakmak","year":"2013","unstructured":"Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99(6):1476\u201384. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2013.03.029.","journal-title":"Fertil Steril"},{"issue":"7","key":"1530_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/S10815-014-0248-6","volume":"31","author":"J Reddy","year":"2014","unstructured":"Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet. 2014;31(7):927\u201332. https:\/\/doi.org\/10.1007\/S10815-014-0248-6.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1530_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/S10815-020-02051-7","volume":"38","author":"J Christ","year":"2021","unstructured":"Christ J, Herndon CN, Yu B. Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients. J Assist Reprod Genet. 2021;38(3):751\u20136. https:\/\/doi.org\/10.1007\/S10815-020-02051-7.","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"1530_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/S10815-019-01556-0","volume":"36","author":"K Wald","year":"2019","unstructured":"\u2022 Wald K, Letourneau J, Eshima-McKay R, et al. Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations. J Assist Reprod Genet. 2019;36(10):2087\u201394. https:\/\/doi.org\/10.1007\/S10815-019-01556-0. This review describes the methods and considerations of ovarian stimulation and egg retrieval in individuals who have a severe medical condition.","journal-title":"J Assist Reprod Genet."},{"issue":"5","key":"1530_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/MOLEHR\/8.5.409","volume":"8","author":"C Albert","year":"2002","unstructured":"Albert C, Garrido N, Mercader A, et al. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod. 2002;8(5):409\u201318. https:\/\/doi.org\/10.1093\/MOLEHR\/8.5.409.","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"1530_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/S10456-008-9099-Z","volume":"11","author":"JA Nagy","year":"2008","unstructured":"Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11(2):109\u201319. https:\/\/doi.org\/10.1007\/S10456-008-9099-Z.","journal-title":"Angiogenesis"},{"issue":"2","key":"1530_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0015-0282(98)00447-6","volume":"71","author":"R Agrawal","year":"1999","unstructured":"Agrawal R, Tan SL, Wild S, et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril. 1999;71(2):287\u201393. https:\/\/doi.org\/10.1016\/S0015-0282(98)00447-6.","journal-title":"Fertil Steril"},{"issue":"6","key":"1530_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/S00520-002-0358-Z","volume":"10","author":"T Morita","year":"2002","unstructured":"Morita T, Tei Y, Inoue S, Suga A, Chihara S. Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study. Support Care Cancer. 2002;10(6):474\u20139. https:\/\/doi.org\/10.1007\/S00520-002-0358-Z.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1530_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/JPM.2019.0392","volume":"23","author":"K Amano","year":"2020","unstructured":"Amano K, Liu D, Bruera E, Hui D. Collapse of fluid balance and association with survival in patients with advanced cancer admitted to a palliative care unit: preliminary findings. J Palliat Med. 2020;23(4):459\u201365. https:\/\/doi.org\/10.1089\/JPM.2019.0392.","journal-title":"J Palliat Med"},{"issue":"2","key":"1530_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/IJGO.12360","volume":"140","author":"YA Bassiouny","year":"2018","unstructured":"Bassiouny YA, Dakhly DMR, Bayoumi YA, Salaheldin NM, Gouda HM, Hassan AA. Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during in vitro fertilization\/intracytoplasmic sperm injection cycles. Int J Gynaecol Obstet. 2018;140(2):217\u201322. https:\/\/doi.org\/10.1002\/IJGO.12360.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"1530_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1472-6483(10)60401-4","volume":"17","author":"C Carizza","year":"2008","unstructured":"Carizza C, Abdelmassih V, Abdelmassih S, et al. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online. 2008;17(6):751\u20135. https:\/\/doi.org\/10.1016\/S1472-6483(10)60401-4.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1530_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/2231-0770.165121","volume":"5","author":"N Kilic","year":"2015","unstructured":"Kilic N, \u00d6zdemir \u00d6, Ba\u015far HC, Demircan F, Ekmez F, Y\u00fccel O. Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment cycles: a randomized controlled study. Avicenna J Med. 2015;5(4):123\u20137. https:\/\/doi.org\/10.4103\/2231-0770.165121.","journal-title":"Avicenna J Med"},{"key":"1530_CR28","doi-asserted-by":"publisher","unstructured":"Tang H, Hunter T, Hu Y, Zhai SD, Sheng X, Hart RJ. Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2012;(2). https:\/\/doi.org\/10.1002\/14651858.CD008605.PUB2","DOI":"10.1002\/14651858.CD008605.PUB2"},{"issue":"1","key":"1530_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/ASHEDUCATION-2014.1.379","volume":"2014","author":"SM Bates","year":"2014","unstructured":"Bates SM. Anticoagulation and in vitro fertilization and ovarian stimulation. Hematology Am Soc Hematol Educ Program. 2014;2014(1):379\u201386. https:\/\/doi.org\/10.1182\/ASHEDUCATION-2014.1.379.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1530_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4419-6518-9_5","volume":"156","author":"LA Kondapalli","year":"2010","unstructured":"Kondapalli LA, Hong F, Gracia CR. Clinical cases in oncofertility. Cancer Treat Res. 2010;156:55\u201367. https:\/\/doi.org\/10.1007\/978-1-4419-6518-9_5.","journal-title":"Cancer Treat Res"},{"issue":"3","key":"1530_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/J.FERTNSTERT.2006.12.068","volume":"88","author":"A Azim","year":"2007","unstructured":"Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril. 2007;88(3):657\u201364. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2006.12.068.","journal-title":"Fertil Steril"},{"issue":"9","key":"1530_CR32","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/S10815-021-02273-3","volume":"38","author":"J Letourneau","year":"2021","unstructured":"Letourneau J, Juarez-Hernandez F, Wald K, et al. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial. J Assist Reprod Genet. 2021;38(9):2455\u201363. https:\/\/doi.org\/10.1007\/S10815-021-02273-3.","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"1530_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/09513590.2016.1177013","volume":"32","author":"N Pereira","year":"2016","unstructured":"Pereira N, Hancock K, Cordeiro CN, Lekovich JP, Schattman GL, Rosenwaks Z. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes\u2020. Gynecol Endocrinol. 2016;32(10):823\u20136. https:\/\/doi.org\/10.1080\/09513590.2016.1177013.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1530_CR34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2174\/1389450121666200220124607","volume":"21","author":"E Ferreiro","year":"2020","unstructured":"Ferreiro E, de Uralde BL, Abreu R, Garc\u00eda-Velasco JA, Mu\u00f1oz E. Aromatase inhibitors for ovarian stimulation in patients with breast cancer. Curr Drug Targets. 2020;21(9):910\u201321. https:\/\/doi.org\/10.2174\/1389450121666200220124607.","journal-title":"Curr Drug Targets"},{"issue":"16","key":"1530_CR35","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.2005.04.011","volume":"23","author":"K Oktay","year":"2005","unstructured":"Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005;23(16):3858\u20139. https:\/\/doi.org\/10.1200\/JCO.2005.04.011.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1530_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/J.RBMO.2019.07.003","volume":"39","author":"E Mu\u00f1oz","year":"2019","unstructured":"Mu\u00f1oz E, Domingo J, de Castro G, et al. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer. Reprod Biomed Online. 2019;39(5):860\u20137. https:\/\/doi.org\/10.1016\/J.RBMO.2019.07.003.","journal-title":"Reprod Biomed Online"},{"key":"1530_CR37","doi-asserted-by":"publisher","unstructured":"Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril. 2013;100(6). https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2013.08.030","DOI":"10.1016\/J.FERTNSTERT.2013.08.030"},{"issue":"5","key":"1530_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/HUMREP\/DEX027","volume":"32","author":"RJ Rodgers","year":"2017","unstructured":"Rodgers RJ, Reid GD, Koch J, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod. 2017;32(5):1033\u201345. https:\/\/doi.org\/10.1093\/HUMREP\/DEX027.","journal-title":"Hum Reprod"},{"issue":"19","key":"1530_CR39","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","volume":"23","author":"K Oktay","year":"2005","unstructured":"Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347\u201353. https:\/\/doi.org\/10.1200\/JCO.2005.05.037.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1530_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/S10549-020-06031-4","volume":"186","author":"MB Moravek","year":"2021","unstructured":"Moravek MB, Confino R, Lawson AK, et al. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation. Breast Cancer Res Treat. 2021;186(2):429\u201337. https:\/\/doi.org\/10.1007\/S10549-020-06031-4.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1530_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/HUMREP\/DEAA029","volume":"35","author":"A Marklund","year":"2020","unstructured":"Marklund A, Eloranta S, Wikander I, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Hum Reprod. 2020;35(4):929\u201338. https:\/\/doi.org\/10.1093\/HUMREP\/DEAA029.","journal-title":"Hum Reprod"},{"issue":"1","key":"1530_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/HUMREP\/DEV288","volume":"31","author":"B Luke","year":"2016","unstructured":"Luke B, Brown MB, Missmer SA, et al. Assisted reproductive technology use and outcomes among women with a history of cancer. Hum Reprod. 2016;31(1):183\u20139. https:\/\/doi.org\/10.1093\/HUMREP\/DEV288.","journal-title":"Hum Reprod"},{"issue":"3","key":"1530_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/CNCR.32546","volume":"126","author":"JM Letourneau","year":"2020","unstructured":"\u2022\u2022 Letourneau JM, Wald K, Sinha N, et al. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020;126(3):487\u201395. https:\/\/doi.org\/10.1002\/CNCR.32546. This study of 329 patients with invasive breast cancer showed no impact of fertility preservation on disease-free survival, including for those with estrogen receptor-positive disease or those treated with neoadjuvant chemotherapy.","journal-title":"Cancer."},{"issue":"4","key":"1530_CR44","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1210\/JC.2015-3878","volume":"101","author":"J Kim","year":"2016","unstructured":"Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016;101(4):1364\u201371. https:\/\/doi.org\/10.1210\/JC.2015-3878.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1530_CR45","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/J.EJCA.2015.05.007","volume":"51","author":"O Goldrat","year":"2015","unstructured":"Goldrat O, Kroman N, Peccatori FA, et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. Eur J Cancer. 2015;51(12):1490\u20136. https:\/\/doi.org\/10.1016\/J.EJCA.2015.05.007.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1530_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/J.FERTNSTERT.2011.10.014","volume":"97","author":"S Friedler","year":"2012","unstructured":"Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97(1):125\u201333. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2011.10.014.","journal-title":"Fertil Steril"},{"issue":"1","key":"1530_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/S10549-017-4288-3","volume":"165","author":"AJ Chien","year":"2017","unstructured":"Chien AJ, Chambers J, Mcauley F, et al. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy. Breast Cancer Res Treat. 2017;165(1):151\u20139. https:\/\/doi.org\/10.1007\/S10549-017-4288-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1530_CR48","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1001\/JAMAONCOL.2022.3677","volume":"8","author":"A Marklund","year":"2022","unstructured":"\u2022\u2022 Marklund A, Lekberg T, Hedayati E, et al. Relapse rates and disease-specific mortality following procedures for fertility preservation at time of breast cancer diagnosis. JAMA Oncol. 2022;8(10):1438\u201346. https:\/\/doi.org\/10.1001\/JAMAONCOL.2022.3677. A nationwide cohort study of women with breast cancer who underwent fertility preservation found that fertility preservation at the time of breast cancer diagnosis was not associated with increased disease-specific mortality or relapse.","journal-title":"JAMA Oncol."},{"issue":"16","key":"1530_CR49","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","volume":"26","author":"AA Azim","year":"2008","unstructured":"Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630\u20135. https:\/\/doi.org\/10.1200\/JCO.2007.14.8700.","journal-title":"J Clin Oncol"},{"issue":"18","key":"1530_CR50","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/nejmoa2212856","volume":"388","author":"AH Partridge","year":"2023","unstructured":"Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, S\u00e6tersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ru\u00edz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, International Breast Cancer Study Group, POSITIVE trial collaborators. POSITIVE trial collaborators interrupting endocrine therapy to attempt pregnancy after breast cancer. N Engl J Med. 2023;388(18):1645\u201356. https:\/\/doi.org\/10.1056\/nejmoa2212856.","journal-title":"N Engl J Med."},{"issue":"6","key":"1530_CR51","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/J.FERTNSTERT.2013.07.1992","volume":"100","author":"H Cakmak","year":"2013","unstructured":"Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673\u201380. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2013.07.1992.","journal-title":"Fertil Steril"},{"issue":"3","key":"1530_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/GCO.0000000000000180","volume":"27","author":"H Cakmak","year":"2015","unstructured":"Cakmak H, Rosen MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol. 2015;27(3):215\u201321. https:\/\/doi.org\/10.1097\/GCO.0000000000000180.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"1530_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/23809000.2017.1308808","volume":"2","author":"JN Hudson","year":"2017","unstructured":"Hudson JN, Stanley NB, Nahata L, Bowman-Curci M, Quinn GP. new promising strategies in oncofertility. Expert Rev Qual Life Cancer Care. 2017;2(2):67\u201378. https:\/\/doi.org\/10.1080\/23809000.2017.1308808.","journal-title":"Expert Rev Qual Life Cancer Care"},{"issue":"2","key":"1530_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12788\/J.SUPONC.0004","volume":"11","author":"M Krishnan","year":"2013","unstructured":"Krishnan M, Temel JS, Wright AA, Bernacki R, Selvaggi K, Balboni T. Predicting life expectancy in patients with advanced incurable cancer: a review. J Support Oncol. 2013;11(2):68\u201374. https:\/\/doi.org\/10.12788\/J.SUPONC.0004.","journal-title":"J Support Oncol"},{"issue":"6","key":"1530_CR55","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","volume":"26","author":"AB Mariotto","year":"2017","unstructured":"Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809\u201315. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0889.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1530_CR56","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/J.CTRV.2014.06.012","volume":"40","author":"D McDermott","year":"2014","unstructured":"McDermott D, Lebb\u00e9 C, Hodi FS, et al. Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. Cancer Treat Rev. 2014;40(9):1056\u201364. https:\/\/doi.org\/10.1016\/J.CTRV.2014.06.012.","journal-title":"Cancer Treat Rev"},{"issue":"25","key":"1530_CR57","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMOA2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363\u201376. https:\/\/doi.org\/10.1056\/NEJMOA2201445.","journal-title":"N Engl J Med"},{"issue":"2","key":"1530_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/PBC.22001","volume":"53","author":"LR Schover","year":"2009","unstructured":"Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53(2):281\u20134. https:\/\/doi.org\/10.1002\/PBC.22001.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1530_CR59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/S10815-018-1131-7","volume":"35","author":"J Assi","year":"2018","unstructured":"Assi J, Santos J, Bonetti T, Serafini PC, Motta ELA, Chehin MB. Psychosocial benefits of fertility preservation for young cancer patients. J Assist Reprod Genet. 2018;35(4):601\u20136. https:\/\/doi.org\/10.1007\/S10815-018-1131-7.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"1530_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/J.YGYNO.2004.12.019","volume":"97","author":"J Carter","year":"2005","unstructured":"Carter J, Rowland K, Chi D, et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol. 2005;97(1):90\u20135. https:\/\/doi.org\/10.1016\/J.YGYNO.2004.12.019.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1530_CR61","first-page":"601","volume":"9","author":"S Ozkan","year":"2008","unstructured":"Ozkan S, Ogce F. Importance of social support for functional status in breast cancer patients. Asian Pac J Cancer Prev. 2008;9(4):601\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"1530_CR62","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/J.1532-5415.2006.00789.X","volume":"54","author":"A Hurria","year":"2006","unstructured":"Hurria A, Hurria A, Zuckerman E, et al. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc. 2006;54(7):1119\u201324. https:\/\/doi.org\/10.1111\/J.1532-5415.2006.00789.X.","journal-title":"J Am Geriatr Soc"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01530-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-024-01530-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01530-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:39:28Z","timestamp":1718185168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-024-01530-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1007\/s11912-024-01530-9","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"3 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}